Hansa Biopharma AB (publ) (HNSBF) Short Interest Ratio & Short Volume $3.00 0.00 (0.00%) As of 04/17/2025 Add Compare Share Share Short Interest Stock AnalysisChartHeadlinesShort InterestBuy This Stock Hansa Biopharma AB (publ) Short Interest DataHansa Biopharma AB (publ) (HNSBF) has a short interest of 648,600 shares. This marks a -0.57% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 1,800 shares to cover all short positions.Current Short Interest648,600 sharesPrevious Short Interest652,300 sharesChange Vs. Previous Month-0.57%Dollar Volume Sold Short$1.95 millionShort Interest Ratio0.0 Days to CoverLast Record DateMarch 31, 2025Today's Trading Volume0 sharesAverage Trading Volume1,800 sharesToday's Volume Vs. Average0% Short Selling Hansa Biopharma AB (publ)? Sign up to receive the latest short interest report for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartHNSBF Short Interest Over TimeHNSBF Days to Cover Over TimeHNSBF Percentage of Float Shorted Over Time Hansa Biopharma AB (publ) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025648,600 shares $1.95 million -0.6%N/A0 $3.00 3/15/2025652,300 shares $1.96 million +0.9%N/A0 $3.00 2/28/2025646,700 shares $1.94 million +0.8%N/A0 $3.00 2/15/2025641,700 shares $1.93 million +95.8%N/A0 $3.00 1/31/2025327,700 shares $983,100.00 -39.8%N/A0 $3.00 1/15/2025544,600 shares $1.63 million +2.0%N/A5446 $3.00 12/31/2024534,000 shares $1.60 million -1.3%N/A890 $3.00 12/15/2024541,000 shares $1.53 million No ChangeN/A1352.5 $2.83 11/30/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 11/15/2024541,000 shares $1.97 million No ChangeN/A0 $3.65 Get the Latest News and Ratings for HNSBF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Hansa Biopharma AB (publ) and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024541,000 shares $1.97 million -0.3%N/A5410 $3.65 10/15/2024542,400 shares $1.59 million No ChangeN/A0 $2.93 9/30/2024542,400 shares $1.59 million +0.3%N/A0 $2.93 9/15/2024541,000 shares $1.59 million -1.0%N/A0 $2.93 8/31/2024546,600 shares $1.60 million +1.7%N/A0 $2.93 8/15/2024537,500 shares $1.57 million +10.9%N/A0 $2.93 7/31/2024484,500 shares $1.42 million -0.9%N/A1615 $2.93 7/15/2024489,000 shares $1.43 million -2.2%N/A0 $2.93 6/30/2024499,900 shares $1.46 million -6.5%N/A0 $2.93 6/15/2024534,700 shares $1.57 million -2.7%N/A0 $2.93 5/31/2024549,700 shares $1.61 million -4.8%N/A0 $2.93 5/15/2024577,600 shares $1.69 million No ChangeN/A0 $2.93 4/30/2024577,600 shares $1.69 million -2.1%N/A0 $2.93 4/15/2024590,200 shares $1.73 million +0.7%N/A0 $2.93 3/31/2024586,300 shares $1.72 million -1.8%N/A0 $2.93 3/15/2024596,900 shares $1.94 million +4.4%N/A746.1 $3.26 2/29/2024571,500 shares $1.86 million -0.2%N/A0 $3.26 2/15/2024572,600 shares $1.86 million +7.7%N/A2863 $3.26 1/15/2024451,800 shares $1.20 million -0.6%N/A4518 $2.65 12/31/2023454,600 shares $1.03 million -0.4%N/A235.2 $2.26 12/15/2023456,200 shares $1.37 million -0.2%N/A0 $3.00 11/30/2023457,000 shares $1.37 million +3.0%N/A0 $3.00 11/15/2023443,500 shares $1.33 million -2.4%N/A0 $3.00 10/31/2023454,500 shares $1.36 million -15.7%N/A0 $3.00 10/15/2023538,800 shares $1.62 million -0.2%N/A5388 $3.00 9/30/2023539,800 shares $2.12 million -0.5%N/A0 $3.93 9/15/2023542,500 shares $2.13 million No ChangeN/A5425 $3.93 8/31/2023542,500 shares $2.13 million +0.4%N/A1629 $3.93 8/15/2023540,200 shares $2.57 million +0.4%N/A0 $4.76 7/31/2023538,300 shares $2.85 million +1.6%N/A2691.5 $5.30Trump and Musk fight back (Ad)Is there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.Click here to see why Jeff believes this is the biggest stock story of the year — and which companie 7/15/2023530,100 shares $2.81 million +3.2%N/A0 $5.30 6/30/2023513,600 shares $2.72 million -0.1%N/A0 $5.30 6/15/2023514,200 shares $2.72 million -0.1%N/A0 $5.30 5/31/2023514,700 shares $2.73 million -0.4%N/A0 $5.30 5/15/2023517,000 shares $2.74 million -0.4%N/A574.4 $5.30 4/30/2023519,100 shares $2.70 million +0.2%N/A0 $5.20 4/15/2023517,900 shares $2.69 million -0.3%N/A0 $5.20 3/31/2023519,200 shares $2.70 million +3.3%N/A0 $5.20 3/15/2023502,600 shares $2.61 million -11.4%N/A5026 $5.20 2/28/2023567,000 shares $2.95 million +2.8%N/A0 $5.20 2/15/2023551,600 shares $2.87 million +16.0%N/A2758 $5.20 1/31/2023475,700 shares $3.14 million -0.9%N/A528.6 $6.60 1/15/2023480,000 shares $2.40 million +9.5%N/A1600 $5.01 12/30/2022438,400 shares $2.16 million -8.8%N/A0 $4.93 12/15/2022480,700 shares $2.37 million +2.0%N/A4807 $4.93 11/30/2022471,200 shares $2.27 million +2.7%N/A0 $4.82 11/15/2022458,700 shares $2.21 million +6.5%N/A655.3 $4.82 10/31/2022430,800 shares $2.48 million +0.5%N/A0 $5.75 10/15/2022428,500 shares $2.46 million -10.8%N/A0 $5.75 9/30/2022480,200 shares $2.76 million +7.9%N/A0 $5.75 9/15/2022445,000 shares $2.56 million +20.5%N/A4450 $5.75 8/31/2022369,400 shares $2.09 million +12.0%N/A284.2 $5.66 8/15/2022329,800 shares $1.87 million -22.2%N/A0 $5.66 7/31/2022424,000 shares $2.40 million +26.9%N/A0 $5.66 7/15/2022334,100 shares $1.89 million -18.6%N/A0 $5.66 6/30/2022410,600 shares $2.32 million -12.3%N/A0 $5.66 6/15/2022467,900 shares $2.65 million -10.6%N/A0 $5.66 5/31/2022523,400 shares $2.96 million -5.4%N/A0 $5.66 5/15/2022553,200 shares $3.13 million -0.7%N/A1383 $5.66 4/30/2022557,000 shares $3.25 million -0.2%N/A5570 $5.84 4/15/2022557,900 shares $3.96 million +0.6%N/A5579 $7.10 3/31/2022554,600 shares $5.13 million +7.9%N/A0 $9.25 3/15/2022513,900 shares $4.75 million -9.6%N/A0 $9.25 2/28/2022568,200 shares $5.26 million +7.4%N/A0 $9.25 2/15/2022528,900 shares $4.89 million +26.7%N/A5289 $9.25 1/31/2022417,400 shares $3.86 million +43.8%N/A0 $9.25 1/15/2022290,300 shares $2.69 million +180.5%N/A725.8 $9.25 12/31/2021103,500 shares $1.05 million -1.1%N/A0 $10.10 12/15/2021104,600 shares $1.06 million -10.0%N/A209.2 $10.10 11/30/2021116,200 shares $2.11 million +10.9%N/A0 $18.20 11/15/2021104,800 shares $1.91 million +0.3%N/A0 $18.20 10/29/2021104,500 shares $1.90 million -5.4%N/A0 $18.20 10/15/2021110,500 shares $2.01 million +0.1%N/A0 $18.20 9/30/2021110,400 shares $2.01 million +1.9%N/A0 $18.20 9/15/2021108,400 shares $1.97 million -27.4%N/A0 $18.20 8/31/2021149,200 shares $2.72 million -2.6%N/A0 $18.20 8/13/2021153,100 shares $2.79 million -23.6%N/A0 $18.20 7/30/2021200,400 shares $3.65 million -16.7%N/A0 $18.20 7/15/2021240,500 shares $4.38 million -9.0%N/A0 $18.20 6/30/2021264,200 shares $4.81 million +33.1%N/A1321 $18.20Trump and Musk fight back (Ad)Is there more to the Musk–Trump relationship than meets the eye? Jeff Brown thinks so — and he believes it has to do with a top-level initiative to build the ultimate military-grade AI system. He’s calling it the “AI Superweapon,” and he says it could soon become the center of global tech dominance. At the core of this initiative? A handful of companies tied to America’s most powerful tech platforms — and investors who act before this goes mainstream may have a rare early edge.Click here to see why Jeff believes this is the biggest stock story of the year — and which companie 6/15/2021198,500 shares $3.25 million -38.7%N/A0 $16.40 5/28/2021323,800 shares $5.31 million +3.4%N/A129.5 $16.40 5/14/2021313,200 shares $5.32 million -8.2%N/A0 $16.99 4/30/2021341,300 shares $5.80 million -13.2%N/A0 $16.99 4/15/2021393,200 shares $6.68 million +18.0%N/A0 $16.99 3/31/2021333,300 shares $5.66 million +15.9%N/A833.3 $16.99 3/15/2021287,500 shares $8.48 million -12.3%N/A0 $29.50 2/26/2021327,800 shares $9.67 million No ChangeN/A0 $29.50 2/12/2021327,800 shares $9.67 million -2.8%N/A0 $29.50 1/29/2021337,200 shares $9.95 million -25.2%N/A3372 $29.50 1/15/2021341,300 shares $10.07 million +107.4%N/A0 $29.50 12/31/2020342,900 shares $10.12 million +0.5%N/A0 $29.50 12/15/2020341,300 shares $10.07 million +107.4%N/A0 $29.50 11/30/2020164,600 shares $4.86 million +207.7%N/A0 $29.50 11/15/202053,500 shares $1.58 million +25.9%N/A535 $29.50 10/30/202042,500 shares $1.19 million -12.9%N/A0 $28.03 10/15/202048,800 shares $1.37 million +0.4%N/A25.7 $28.03 9/30/202048,600 shares $1.32 million -0.2%N/A486 $27.14 9/15/202048,700 shares $1.32 million +0.2%N/A0 $27.14 8/31/202048,600 shares $1.32 million +0.2%N/A0 $27.14 8/14/202048,500 shares $1.39 million -24.8%N/A0 $28.65 7/31/202064,500 shares $1.85 million -53.5%N/A13.7 $28.65 7/15/2020138,700 shares $3.70 million -25.3%N/A693.5 $26.70 6/30/2020185,600 shares $4.96 million -21.3%N/A1856 $26.70 6/15/2020235,700 shares $4.24 million -17.8%N/A0 $17.97 5/29/2020286,600 shares $3.81 million -22.9%N/A0 $13.30 5/15/2020371,900 shares $4.95 million -16.8%N/A0 $13.30 4/30/2020446,800 shares $3.73 million +3.4%N/A893.6 $8.34 HNSBF Short Interest - Frequently Asked Questions What is Hansa Biopharma AB (publ)'s current short interest? Short interest is the volume of Hansa Biopharma AB (publ) shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 648,600 shares of HNSBF short. Learn More on Hansa Biopharma AB (publ)'s current short interest. Is Hansa Biopharma AB (publ)'s short interest increasing or decreasing? Hansa Biopharma AB (publ) saw a decrease in short interest during the month of March. As of March 31st, there was short interest totaling 648,600 shares, a decrease of 0.6% from the previous total of 652,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Hansa Biopharma AB (publ) stock? Short selling HNSBF is an investing strategy that aims to generate trading profit from Hansa Biopharma AB (publ) as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Hansa Biopharma AB (publ)? A short squeeze for Hansa Biopharma AB (publ) occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HNSBF, which in turn drives the price of the stock up even further. How often is Hansa Biopharma AB (publ)'s short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HNSBF, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies 3SBio Short Interest Data Agentix Short Interest Data Algernon Pharmaceuticals Short Interest Data Apollomics Short Interest Data Ascentage Pharma Group International Short Interest Data Avacta Group Short Interest Data Awakn Life Sciences Short Interest Data AXIM Biotechnologies Short Interest Data BriaCell Therapeutics Short Interest Data Cardio Diagnostics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:HNSBF) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredRead before the next tariff announcementLarry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hansa Biopharma AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Share Hansa Biopharma AB (publ) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
